Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02234856 · ClinicalTrials.gov registry record · NA
Evaluation of Laparoscopic Hysterectomy Simulator
A NA study, sponsored by Unity Health Toronto.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02234856: Completed NA study, sponsored by Unity Health Toronto.
NCT02234856 is a NA study that has completed, run by Unity Health Toronto. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02234856, a NA study, has completed, sponsored by Unity Health Toronto.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study aims to test the validity of a new educational tool in the form of a computer based video surgical simulator, that may be used to enhance the current teaching method of how to perform a hysterectomy.
Primary Outcome
Phase I will consist of two on line tests that assess surgical and anatomic knowledge. The tests will be separated by 7-10 days. Evaluation will determine the validity of the tests as well as creating a "knowledge curve." Analyzing resident and faculty performance with a one-way analysis of variance, with level of training as the independent variable, will assess construct validity. Post hoc contrasts are done with Student-Newman-Keuls test. We will also evaluate the validity of the exam by comp
Interventions
- PROCEDURE Laparoscopic Hysterectomy trainer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-07 |
| Phase | NA |
What the finished NCT02234856 record still lists
NCT02234856 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Laparoscopic Hysterectomy trainer is the first listed.
NCT02234856 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02234856 about?
NCT02234856 is a clinical study titled "Evaluation of Laparoscopic Hysterectomy Simulator". This study aims to test the validity of a new educational tool in the form of a computer based video surgical simulator, that may be used to enhance the current teaching method of how to perform a hysterectomy.
What is the current status of trial NCT02234856?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2014-07. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02234856?
The interventions under investigation include: Laparoscopic Hysterectomy trainer (PROCEDURE).
Who is sponsoring clinical trial NCT02234856?
This trial is sponsored by Unity Health Toronto, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02234856's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia